| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Republic of Korea | 4 | |
| #3 | China | 1 | |
| #4 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Foods and drinks | |
| #3 | Biotechnology | |
| #4 | Measurement | |
| #5 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Foods | |
| #4 | Analysing materials | |
| #5 | Peptides | |
| #6 | Specific use of cosmetics | |
| #7 | Microorganisms | |
| #8 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Choi Jung Ho | 4 |
| #2 | Lee Jeong Min | 4 |
| #3 | Noh Ill Chan | 4 |
| #4 | Choi Ji Na | 4 |
| #5 | Choi Kyu Seok | 2 |
| #6 | Hong Jin Tea | 2 |
| #7 | Kwon Seok Young | 2 |
| #8 | Kim Se Na | 2 |
| #9 | Park Jae Won | 2 |
| #10 | Koo Dae Hwan | 2 |
| Publication | Filing date | Title |
|---|---|---|
| KR102062791B1 | Pharmaceutical formulation for controlled release containing mirabegron or pharmaceutically acceptable salts thereof as an active ingredient | |
| KR20190130411A | Pharmaceutical formulation comprising apixaban and method for preparing the same | |
| WO2019189990A1 | Breast cancer diagnosis composition using multiple autoantibodies and breast cancer diagnosis kit using same | |
| KR20180039919A | Fab fragment and uses thereof | |
| KR20180038622A | Pharmaceutical Composition Containing Linagliptin and Preparing Method Thereof |